The Wall Street Journal reports on innovative approaches to getting people to enroll in clinical trials, including one that it describes as "a sort of medical matchmaker that is gaining wider usage: EmergingMed, a for-profit service that connects patients to cutting-edge clinical trials." Let's hope one of these programs works. While they may not realize it, consumers are an essential part of the biomedical enterprise and new treatments can't emerge without them.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.